|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||220.50 - 225.75|
|52-week range||187.25 - 239.41|
|Beta (5Y monthly)||0.12|
|PE ratio (TTM)||42.32|
|Forward dividend & yield||2.21 (1.00%)|
|Ex-dividend date||02 Sept 2021|
|1y target est||N/A|
CSL's Global Chief Human Resources Officer Elizabeth Walker has been appointed to the Urban League of Philadelphia's Board of Directors.
CSL Plasma today announced it will provide influenza (flu) vaccination vouchers to U.S. plasma donors following the completion of two plasma donations made within a calendar month. Beginning Sept. 1, donors can redeem vouchers for the vaccine at no cost at Walgreens pharmacy locations across the U.S. after completion of their second donation.
Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced plans to accelerate the development of its next generation of messenger RNA (mRNA) vaccine technology, self-amplifying messenger RNA (sa-mRNA), with the creation of a dedicated sa-mRNA program and senior leadership appointment.